oc000203 10.3205/oc000203 urn:nbn:de:0183-oc0002037 Case Report Özyol Özyol Erhan E MD

SANKO Üniversitesi, Tip Fakültesi, Göz Hastalıkları, AD 27000, Gaziantep, Turkey, Phone: +90 3422115000SANKO University, Faculty of Medicine, Department of Ophthalmology, Gaziantep, Turkey

ozyolerhan@gmail.com author Özyol Özyol Pelin P

SANKO University, Faculty of Medicine, Department of Ophthalmology, Gaziantep, Turkey

author German Medical Science GMS Publishing House

Düsseldorf

610 acute zonal occult outer retinopathy optical coherence tomography optical coherence tomography angiography 20220609 engl This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). 2193-1496 12 GMS Ophthalmology Cases GMS Ophthalmol Cases 16 Acute zonal occult outer retinopathy (AZOOR) is a rare condition primarily affecting the outer retina based on electrophysiologic studies. In addition to characteristic fundus appearance, spectral domain optical coherence tomography and fundus autofluorescence are unique in diagnosing AZOOR. There are a few reports on optical coherence tomography anjiography (OCTA) in AZOOR disease. In this report, we present a case using multimodal imaging including OCTA and treatment response to combined systemic antiviral, antiinflammatory, and immunosuppressive drugs. En-face OCTA outer retinal slab may provide useful tips for diagnosis and treatment response. IntroductionAcute zonal occult outer retinopathy (AZOOR), first reported by Gass in 1992 , typically affects young adult women who present with central vision loss with or without photopsia due to rapid loss of one or more large zones of outer retinal function. The exact pathogenesis of the disease is not well known. Infectious, autoimmune, or inflammatory etiologies were supposed to be responsible in the emergence of disease , . Few studies have described the role of multimodal imaging in AZOOR , . A common consensus has not been achieved for treatment in the literature.We have evaluated clinical features of AZOOR in a 64-year-old man using multimodal imaging including optical coherence tomography angiography (OCTA) (AngioVue, RTVue XR Avanti; Optovue, Inc., Freemont, CA, USA) and treatment response to combined systemic antiviral and immunsupressive drugs during follow-up. Case descriptionA 64-year-old man presented with sudden onset decrease in vision and photopsia in the right eye since 10 days. Systemic and ocular history was normal. There was no viral infection history preceding the symptoms. The best corrected visual acuity (BCVA) in the patient’s right eye was counting fingers at 2 m and 9/10 in his left eye. There was nuclear sclerosis in both eyes. Fundus examination demonstrated an annular ring of yellowish reflex with an about 4–5 disc diameter at the posterior pole in the right eye (Figure 1 ). Anterior uveitis or vitritis was not detected. There was slightly increased hyperautofluorescence, more prominent at the temporal border on fundus autofluorescence (FAF) imaging (Figure 2 ). Infrared fundus image showed the lesion contour consistent with the FAF and color images (Figure 3 ). Spectral domain optical coherence tomography (SD-OCT) revealed hyperreflective dots between the retinal pigment epithelium (RPE) and the ellipsoid zone (EZ) and loss or irregularity of the EZ (Figure 4 ). En-face OCTA outer retinal slab demonstrated multiple hyperreflective dots in a starry-sky appearance (Figure 5 ). The patient was diagnosed as AZOOR and started on oral valgancyclovir (1 g three times daily for a week, once a day for 3 weeks), oral azathioprine (50 mg three times daily) and a weekly tapering course of oral prednisolone (starting at 1 mg/kg body weight). At 2-week examination, significant visual and anatomical improvements were observed. BCVA in the right eye improved to 6/10. The retinal lesion with annular ring of yellowish reflex disappeared (Figure 6 , Figure 7 ). There was a marked recovery in the EZ and the outer segment of the photoreceptors on SD-OCT images (Figure 8 ). En-face structural OCTA images showed an obvious decrease in the hyperreflective dots (Figure 9 ). The patient was kept under the same treatment and the follow-up continued. The left eye was not affected during the follow-up. DiscussionAlthough AZOOR was first described in 1992 , its etiopathogenesis and treatment remain unclear. Based on the electrophysiologic studies, the primary lesions in AZOOR were suggested as the dysfunction and/or degeneration of the photoreceptor outer segment .The fundus view may be normal or damaged at different levels, depending on the stage of the disease and the location of the lesion , , . However, some features were reported as characteristic, including a demarcating line of the progression at the level of the outer retina and a trizonal pattern of sequential involvement of the outer retina, retinal pigment epithelium, and choroid, as well as frequent zonal progression. AZOOR can manifest as unilateral and asymmetric lesions that have a delineating line to segregate the normal fundus from the AZOOR lesion .Supporting the characteristic color fundus images with SD-OCT and FAF images is very important in the diagnosis of AZOOR. OCTA is a non-invasive, innovative technology for imaging the microvasculature of the retina and the choroid. OCTA has been reported to be useful in the diagnosis and understanding of many retinal conditions .There are a few reports on OCTA in AZOOR disease in the literature. In the first report by Levison et al. in 2016 , OCTA was used only to confirm the presence of choroid neovascular membrane in AZOOR. In another case reported by Naik et al. in 2018 , the structural en-face OCTA images demonstrated the hyper-reflective dot structures leading to a starry-sky view at presentation. The authors postulated these hyper-reflective dots as degenerating photoreceptor segments. Mehrotra et al. presented an AZOOR case with an orange-yellow-colored demarcation line in the peripapillary area. In that case, the OCTA panorama showed an increased decorrelation signal at the deeper capillary plexus along with the projection artifacts of the superficial capillary plexus. The authors have postulated that an OCTA panorama centered on the fovea with a wider field of view can prove as a potential imaging marker and can subserve as an additional tool to FAF to accurately diagnose and manage AZOOR. In our case, the OCTA findings were in agreement with the report by Naik et al. . Hyperreflective dots in a starry-sky appearance on en-face OCTA outer retinal slab may be characteristic when evaluated with other typical findings both in diagnosis and treatment response.There are some treatment approaches including observation without any treatment, immunosuppressive agents, systemic or intravitreal steroids, and antiviral therapy, and the results were reported in contradiction to one another , , , , , , . In a study of 51 patients reported by Gass et al. , systemic corticosteroids were used in 39 of 113 instances of acute visual loss. The authors reported no difference between treated and non-treated patients. In the same study, systemic steroid and acyclovir or valacyclovir were prescribed for 11 episodes without apparent therapeutic benefit. The authors concluded that there was no treatment of proven value. In a case report by Hoang et al. , treatment with antiviral and immunomodulatory drugs failed to control the disease progression. Rodriguez-Coleman et al. reported a case that was given a treatment trial of systemic steroids and acyclovir with no clinical benefit. In contrast, Kitakawa et al. reported a case treated with pulse steroids, followed by oral prednisolone tapered over one month, and improvements in visual acuity and imaging findings after fourteen months. Chen et al. indicated beneficial results of systemic steroids in a retrospective study with a mean follow-up of 47 months. In a retrospective case series, disease stability or improvement was reported after intravitreal steroids. It was noted that treatment-related ocular side effects such as cataract, ocular hypertension, and central serous retinopathy were remarkable . Mahajan and Stone reported 3 cases with a presumptive diagnosis of AZOOR that were responsive to oral valacyclovir without steroid use. Nakao et al. presented a case diagnosed with AZOOR with spontaneous remission without any treatment after two months.The predictability of the disease is low due to insufficient data. Referring to recent publications, stabilization has been reported to have occurred within 6 months in the majority of patients , . However, in a small percentage of cases, the disease continued to worsen after 6 months . In our case, significant improvement in both anatomic and visual function was detected in the second week after combined drug treatment. This improvement continued up to the 2-month examination.The limitation of the case report is the lack of the anterior chamber or vitreous tap for detecting viral etiology. Although the cause of the disease is unknown, autoimmunity or viral causes are considered in the foreground , . Gass et al. suggested several reasons for viral etiology, including the asymmetrical nature of the disease; the lack of response to the administration of corticosteroids; the lack of correlation between a history of autoimmune conditions, bilateral disease and disease severity; the absence of a family history of AZOOR; and the absence of circulating retinal antibodies in many patients. We also know that many autoimmune disorders tend to affect young women . In our case, we thought about a possible viral etiology because of the patient’s age and gender, the absence of a systemic history of autoimmune diseases, the asymmetric nature of retinal involvement, and the unilateral presentation of the disease. Because of this, valgancyclovir was added to the prescription. Despite the potential to be bilateral, the second eye was not involved during the follow-up period. The choroid was not affected during follow-up. Both unilateral involvement and limited zonal damage may be associated with early diagnosis and initiation of broad-spectrum systemic therapy. Since immunosuppressive agents take many weeks to have an effect, improvement of the clinical findings in the early weeks are most probably due to the systemic steroids. Valgancyclovir may contribute to the absence of a late worsening of the clinical findings at two months. However, this needs to be verified. Surely, a spontaneous remission is also possible. Even if the treatment described has led to improved findings, this does not mean that there is a causal relationship between diagnosis and therapy.Undoubtedly, further studies with a longer follow-up and a larger series are needed to reach a conclusion on etiology and treatment. In addition to other diagnostic tools, OCTA can provide lock tips in diagnosis and follow-up in AZOOR. NotesCompeting interestsThe authors declare that they have no competing interests. Gass JD Acute zonal occult outer retinopathy. Donders Lecture: The Netherlands Ophthalmological Society, Maastricht, Holland, June 19, 1992 1993 J Clin Neuroophthalmol 79-97 Gass JD. Acute zonal occult outer retinopathy. Donders Lecture: The Netherlands Ophthalmological Society, Maastricht, Holland, June 19, 1992. J Clin Neuroophthalmol. 1993 Jun;13(2):79-97. Jampol LM Becker KG White spot syndromes of the retina: a hypothesis based on the common genetic hypothesis of autoimmune/inflammatory disease 2003 Am J Ophthalmol 376-9 Jampol LM, Becker KG. White spot syndromes of the retina: a hypothesis based on the common genetic hypothesis of autoimmune/inflammatory disease. Am J Ophthalmol. 2003 Mar;135(3):376-9. DOI: 10.1016/s0002-9394(02)02088-3 https://doi.org/10.1016/s0002-9394(02)02088-3 Mrejen S Khan S Gallego-Pinazo R Jampol LM Yannuzzi LA Acute zonal occult outer retinopathy: a classification based on multimodal imaging 2014 JAMA Ophthalmol 1089-98 Mrejen S, Khan S, Gallego-Pinazo R, Jampol LM, Yannuzzi LA. Acute zonal occult outer retinopathy: a classification based on multimodal imaging. JAMA Ophthalmol. 2014 Sep;132(9):1089-98. DOI: 10.1001/jamaophthalmol.2014.1683 https://doi.org/10.1001/jamaophthalmol.2014.1683 Duncker T Lee W Jiang F Ramachandran R Hood DC Tsang SH Sparrow JR Greenstein VC Acute zonal occult outer retinopathy: Structural and Functional Analysis Across the Transition Zone Between Healthy and Diseased Retina 2018 Retina 118-27 Duncker T, Lee W, Jiang F, Ramachandran R, Hood DC, Tsang SH, Sparrow JR, Greenstein VC. Acute zonal occult outer retinopathy: Structural and Functional Analysis Across the Transition Zone Between Healthy and Diseased Retina. Retina. 2018 Jan;38(1):118-27. DOI: 10.1097/IAE.0000000000001513 https://doi.org/10.1097/IAE.0000000000001513 Li D Kishi S Loss of photoreceptor outer segment in acute zonal occult outer retinopathy 2007 Arch Ophthalmol 1194-200 Li D, Kishi S. Loss of photoreceptor outer segment in acute zonal occult outer retinopathy. Arch Ophthalmol. 2007 Sep;125(9):1194-200. DOI: 10.1001/archopht.125.9.1194 https://doi.org/10.1001/archopht.125.9.1194 Rodriguez-Coleman H Bryan RG Donsoff I Nicoletti R Yannuzzi LA Zonal occult outer retinopathy 2002 Retina 665-9 Rodriguez-Coleman H, Bryan RG, Donsoff I, Nicoletti R, Yannuzzi LA. Zonal occult outer retinopathy. Retina. 2002 Oct;22(5):665-9. DOI: 10.1097/00006982-200210000-00026 https://doi.org/10.1097/00006982-200210000-00026 Smetana S Feman SS Kleber C The retinal features of acute zonal occult outer retinopathy (AZOOR) 2003 Arch Ophthalmol 914-5 Smetana S, Feman SS, Kleber C. The retinal features of acute zonal occult outer retinopathy (AZOOR). Arch Ophthalmol. 2003 Jun;121(6):914-5. DOI: 10.1001/archopht.121.6.914 https://doi.org/10.1001/archopht.121.6.914 Spaide RF Collateral damage in acute zonal occult outer retinopathy 2004 Am J Ophthalmol 887-9 Spaide RF. Collateral damage in acute zonal occult outer retinopathy. Am J Ophthalmol. 2004 Nov;138(5):887-9. DOI: 10.1016/j.ajo.2004.06.001 https://doi.org/10.1016/j.ajo.2004.06.001 Samara WA Shahlaee A Adam MK Khan MA Chiang A Maguire JI Hsu J Ho AC Quantification of Diabetic Macular Ischemia Using Optical Coherence Tomography Angiography and Its Relationship with Visual Acuity 2017 Ophthalmology 235-44 Samara WA, Shahlaee A, Adam MK, Khan MA, Chiang A, Maguire JI, Hsu J, Ho AC. Quantification of Diabetic Macular Ischemia Using Optical Coherence Tomography Angiography and Its Relationship with Visual Acuity. Ophthalmology. 2017 Feb;124(2):235-44. DOI: 10.1016/j.ophtha.2016.10.008 https://doi.org/10.1016/j.ophtha.2016.10.008 Levison AL Baynes K Lowder CY Srivastava SK OCT Angiography Identification of Choroidal Neovascularization Secondary to Acute Zonal Occult Outer Retinopathy 2016 Ophthalmic Surg Lasers Imaging Retina 73-5 Levison AL, Baynes K, Lowder CY, Srivastava SK. OCT Angiography Identification of Choroidal Neovascularization Secondary to Acute Zonal Occult Outer Retinopathy. Ophthalmic Surg Lasers Imaging Retina. 2016 Jan;47(1):73-5. DOI: 10.3928/23258160-20151214-11 https://doi.org/10.3928/23258160-20151214-11 Naik AU Ezhilvathani N Biswas J Acute zonal occult outer retinopathy: Is optical coherence tomography angiography useful? 2018 Indian J Ophthalmol 1637-9 Naik AU, Ezhilvathani N, Biswas J. Acute zonal occult outer retinopathy: Is optical coherence tomography angiography useful? Indian J Ophthalmol. 2018 Nov;66(11):1637-9. DOI: 10.4103/ijo.IJO_966_18 https://doi.org/10.4103/ijo.IJO_966_18 Mehrotra N Nagpal M Khandelwal J Juneja R Panoramic optical coherence tomography angiography features in acute zonal occult outer retinopathy 2018 Indian J Ophthalmol 1856-8 Mehrotra N, Nagpal M, Khandelwal J, Juneja R. Panoramic optical coherence tomography angiography features in acute zonal occult outer retinopathy. Indian J Ophthalmol. 2018 Dec;66(12):1856-8. DOI: 10.4103/ijo.IJO_826_18 https://doi.org/10.4103/ijo.IJO_826_18 Gass JD Agarwal A Scott IU Acute zonal occult outer retinopathy: a long-term follow-up study 2002 Am J Ophthalmol 329-39 Gass JD, Agarwal A, Scott IU. Acute zonal occult outer retinopathy: a long-term follow-up study. Am J Ophthalmol. 2002 Sep;134(3):329-39. DOI: 10.1016/s0002-9394(02)01640-9 https://doi.org/10.1016/s0002-9394(02)01640-9 Hoang QV Gallego-Pinazo R Yannuzzi LA Long-term follow-up of acute zonal occult outer retinopathy 2013 Retina 1325-7 Hoang QV, Gallego-Pinazo R, Yannuzzi LA. Long-term follow-up of acute zonal occult outer retinopathy. Retina. 2013 Jul-Aug;33(7):1325-7. DOI: 10.1097/IAE.0b013e318286cc57 https://doi.org/10.1097/IAE.0b013e318286cc57 Kitakawa T Hayashi T Takashina H Mitooka K Gekka T Tsuneoka H Improvement of central visual function following steroid pulse therapy in acute zonal occult outer retinopathy 2012 Doc Ophthalmol 249-54 Kitakawa T, Hayashi T, Takashina H, Mitooka K, Gekka T, Tsuneoka H. Improvement of central visual function following steroid pulse therapy in acute zonal occult outer retinopathy. Doc Ophthalmol. 2012 Jun;124(3):249-54. DOI: 10.1007/s10633-012-9318-1 https://doi.org/10.1007/s10633-012-9318-1 Chen SN Yang CH Yang CM Systemic corticosteroids therapy in the management of acute zonal occult outer retinopathy 2015 J Ophthalmol 793026 Chen SN, Yang CH, Yang CM. Systemic corticosteroids therapy in the management of acute zonal occult outer retinopathy. J Ophthalmol. 2015;2015:793026. DOI: 10.1155/2015/793026 https://doi.org/10.1155/2015/793026 Barnes AC Lowder CY Bessette AP Baynes K Srivastava SK Treatment of Acute Zonal Occult Outer Retinopathy With Intravitreal Steroids 2018 Ophthalmic Surg Lasers Imaging Retina 504-9 Barnes AC, Lowder CY, Bessette AP, Baynes K, Srivastava SK. Treatment of Acute Zonal Occult Outer Retinopathy With Intravitreal Steroids. Ophthalmic Surg Lasers Imaging Retina. 2018 Jul;49(7):504-9. DOI: 10.3928/23258160-20180628-06 https://doi.org/10.3928/23258160-20180628-06 Mahajan VB Stone EM Patients with an acute zonal occult outer retinopathy-like illness rapidly improve with valacyclovir treatment 2010 Am J Ophthalmol 511-8 Mahajan VB, Stone EM. Patients with an acute zonal occult outer retinopathy-like illness rapidly improve with valacyclovir treatment. Am J Ophthalmol. 2010 Oct;150(4):511-8. DOI: 10.1016/j.ajo.2010.05.024 https://doi.org/10.1016/j.ajo.2010.05.024 Nakao S Kaizu Y Yoshida S Iida T Ishibashi T Spontaneous remission of acute zonal occult outer retinopathy: follow-up using adaptive optics scanning laser ophthalmoscopy 2015 Graefes Arch Clin Exp Ophthalmol 839-43 Nakao S, Kaizu Y, Yoshida S, Iida T, Ishibashi T. Spontaneous remission of acute zonal occult outer retinopathy: follow-up using adaptive optics scanning laser ophthalmoscopy. Graefes Arch Clin Exp Ophthalmol. 2015 Jun;253(6):839-43. DOI: 10.1007/s00417-014-2760-x https://doi.org/10.1007/s00417-014-2760-x Monson DM Smith JR Acute zonal occult outer retinopathy 2011 Surv Ophthalmol 23-35 Monson DM, Smith JR. Acute zonal occult outer retinopathy. Surv Ophthalmol. 2011 Jan-Feb;56(1):23-35. DOI: 10.1016/j.survophthal.2010.07.004 https://doi.org/10.1016/j.survophthal.2010.07.004 Saito S Saito W Saito M Hashimoto Y Mori S Noda K Namba K Ishida S Acute zonal occult outer retinopathy in Japanese patients: clinical features, visual function, and factors affecting visual function 2015 PLoS One e0125133 Saito S, Saito W, Saito M, Hashimoto Y, Mori S, Noda K, Namba K, Ishida S. Acute zonal occult outer retinopathy in Japanese patients: clinical features, visual function, and factors affecting visual function. PLoS One. 2015 Apr;10(4):e0125133. DOI: 10.1371/journal.pone.0125133 https://doi.org/10.1371/journal.pone.0125133 Jampol LM Wiredu A MEWDS, MFC, PIC, AMN, AIBSE, and AZOOR: one disease or many? 1995 Retina 373-8 Jampol LM, Wiredu A. MEWDS, MFC, PIC, AMN, AIBSE, and AZOOR: one disease or many? Retina. 1995;15(5):373-8. DOI: 10.1097/00006982-199515050-00001 https://doi.org/10.1097/00006982-199515050-00001 Angum F Khan T Kaler J Siddiqui L Hussain A The Prevalence of Autoimmune Disorders in Women: A Narrative Review 2020 Cureus e8094 Angum F, Khan T, Kaler J, Siddiqui L, Hussain A. The Prevalence of Autoimmune Disorders in Women: A Narrative Review. Cureus. 2020 May;12(5):e8094. DOI: 10.7759/cureus.8094 https://doi.org/10.7759/cureus.8094 0

1 1 Figure 1: Fundus images at the time of diagnosis(a) Fundus appearance of the AZOOR lesion as an annular ring of yellowish reflex with an about 4–5 disc diameter in the right eye, (b) fundus photo showing the normal left eye

2 2 Figure 2: FAF images at the time of diagnosis(a) Slightly increased autofluorescence, more prominent at the border on FAF imaging in the right eye, (b) normal autofluorescence image of the left eye

3 3 Figure 3: Infrared (IR) images at the time of diagnosis(a) IR image of the right eye showed the lesion contour consistent with the FAF and color images, (b) IR image of the left eye

4 4 Figure 4: SD-OCT images at the time of diagnosis(a) Spectral domain optical coherence tomography (SD-OCT) revealed hyperreflective dots between RPE and the ellipsoid zone (EZ) and loss or irregularity of the EZ, (b) SD-OCT image of the left eye

5 5 Figure 5: OCTA images at the time of diagnosis (a) Multiple hyperreflective dots in a starry-sky appearance on the en-face OCTA outer retinal slab of the right eye, (b) OCTA image of the left eye

6 6 Figure 6: Fundus images at 2-week examination after the treatment(a) The retinal lesion with the annular ring of yellowish reflex disappeared on the color fundus image of the right eye, (b) view of left fundus

7 7 Figure 7: FAF images at 2-week examination after the treatment(a) FAF image of the right eye, (b) FAF image of the left eye

8 8 Figure 8: SD-OCT images at 2-week examination after the treatment(a) Marked recovery in EZ and outer segment of photoreceptors on SD-OCT images in the right eye, (b) SD-OCT image of the left eye

9 9 Figure 9: OCTA images at 2-week examination after the treatment(a) An obvious decrease in the hyperreflective dots on en-face OCTA, (b) en-face OCTA image of the left eye

9 0 0